Dove vs Johnson & Johnson

Unilever's Al Hajji: Attention is Hard to Earn, Easy to Lose

At The Drum Live, Unilever's Chief Growth and Transformation Officer for Personal Care, Rani Al Hajji, discussed the company's 2026 World Cup sponsorship. He emphasized that attention is now extremely difficult to earn and easy to lose, making relevance crucial. Unilever activated 35 brands across 120 markets, using a 'poetry and plumbing' approach: creative brand ideas supported by a system of creators, content, data, and commerce. Brands like Dove, Sure, and Lynx developed distinct roles, with physical hubs (House of Fresh) in major cities to engage creators and consumers. Al Hajji stressed the importance of selecting creators for community fit over reach, and the need to integrate commerce to turn attention into demand. He acknowledged that results are not yet official but sees potential for a repeatable demand generation system.

• Unilever activated 35 brands across 120 markets for the 2026 World Cup.
• The company created physical hubs called 'House of Fresh' in New York, Miami, and Mexico City.
• Dove, Sure, and Lynx each had distinct brand activations during the tournament.

Dove: 20+ Years of the 'Real Beauty' Campaign

This feature retrospective (published 2026-08-13) reviews over 20 years of Dove's 'Real Beauty' campaign, originally launched in 2004. The article notes that Dove (a Unilever brand) and agency Ogilvy created the 'Real Beauty' platform and presents what the authors consider the ten most moving advertisements and appearances from the campaign's history. The piece positions 'Real Beauty' as a benchmark for values-driven brand campaigns and traces its origin to a Dove brand relaunch roughly 22 years ago.

• Dove and Ogilvy created the 'Real Beauty' campaign platform in 2004.
• Dove is identified as a Unilever brand in the article.
• The article is a retrospective showcasing the ten most notable 'Real Beauty' ad appearances from over 20 years.

Dove 'Beauty Machine' OOH Reveals Algorithmic Beauty Bias

Dove, with lead agency Ogilvy UK, launched an experiential Out-of-Home installation called "The Beauty Machine" to demonstrate how social-media recommendation algorithms favor a narrow, homogeneous beauty ideal. The travelling installation appeared in London (Waterloo Station), Hamburg and at Cannes Lions, showing composite masks derived from thousands of social media images to illustrate algorithmic repetition. The campaign includes a #DoveOpenCall asking women to submit unfiltered photos that will be amplified via OOH and social channels. Dove positions the activation within its long-running "Real Beauty" platform; Unilever reports Dove remains a growth driver in H1 2026. The initiative also references academic research and a 2025 Leibniz-Institute report calling for algorithmic interventions to increase visible diversity online.

• Dove and lead agency Ogilvy UK created the travelling OOH installation "The Beauty Machine" shown in London (Waterloo Station), Hamburg and Cannes.
• The installation used custom masks generated after analyzing thousands of social media images to create an algorithmic composite labeled the "One Face of Beauty."
• The campaign includes a public #DoveOpenCall for women to submit unfiltered photos to be used in subsequent OOH and social creative.

A behind-the-scenes look at how Johnson & Johnson manufactures and delivers CAR-T cell therapy for multiple myeloma

Transforming cancer patients’ own cells into a targeted treatment is a complex and nuanced process. Jessica Torfs, director of Global CAR-T Supply Chain at Johnson & Johnson, explains what it takes to deliver this cutting-edge personalized therapy.

Johnson & Johnson announces TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to show significant improvement in spinal pain and stiffness in landmark axial psoriatic arthritis (PsA) study

Topline results show TREMFYA met the primary and major secondary endpoints of axial involvement in PsA - including spinal pain and stiffness - and demonstrated significant improvement in MRI-confirmed inflammation. First-ever study to use objective MRI assessments to confirm presence of axial involvement and demonstrate axial inflammation reduction in PsA.

8-K Financial Filing Analysis for Johnson & Johnson

Johnson & Johnson filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) on July 15, 2026, announcing its financial results for the fiscal second quarter ended June 28, 2026. The filing furnishes the official quarterly press release alongside unaudited comparative supplementary sales data and condensed consolidated statements of earnings for both the second quarter and the first six months of the fiscal year.

• Johnson & Johnson released its sales and earnings report for the second quarter ended June 28, 2026, via Item 2.02.
• The filing includes Exhibit 99.1 (Press Release) and Exhibit 99.2 (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings).
• The report was formally signed on July 15, 2026, by Controller and Principal Accounting Officer Robert J. Decker, Jr.